<code id='CE20FB6DD6'></code><style id='CE20FB6DD6'></style>
    • <acronym id='CE20FB6DD6'></acronym>
      <center id='CE20FB6DD6'><center id='CE20FB6DD6'><tfoot id='CE20FB6DD6'></tfoot></center><abbr id='CE20FB6DD6'><dir id='CE20FB6DD6'><tfoot id='CE20FB6DD6'></tfoot><noframes id='CE20FB6DD6'>

    • <optgroup id='CE20FB6DD6'><strike id='CE20FB6DD6'><sup id='CE20FB6DD6'></sup></strike><code id='CE20FB6DD6'></code></optgroup>
        1. <b id='CE20FB6DD6'><label id='CE20FB6DD6'><select id='CE20FB6DD6'><dt id='CE20FB6DD6'><span id='CE20FB6DD6'></span></dt></select></label></b><u id='CE20FB6DD6'></u>
          <i id='CE20FB6DD6'><strike id='CE20FB6DD6'><tt id='CE20FB6DD6'><pre id='CE20FB6DD6'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:753
          Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT
          Molly Ferguson for STAT

          The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

          Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

          advertisement

          All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Sanofi CEO defends move to abandon profit guidance, boost research
          Sanofi CEO defends move to abandon profit guidance, boost research

          SanofiCEOPaulHudsonCarolynKaster/APLONDON—SanofiCEOPaulHudsononWednesdaydefendedhiscompany’srecentmo

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

          AdobeLife-sciencecompanieshavechangedtheworldwiththebreakthroughvaccinesandtherapeuticstheycreated—a